CA-QVEST-GROUP
8.12.2020 20:52:10 CET | Business Wire | Press release
The Qvest Group, a world-leading systems architect and ICT integrator, today announced the acquisition of the majority of OnPrem Solution Partners LLC, a highly reputed consultancy across the media and entertainment supply chain in the USA. OnPrem’s expertise in business and technology consulting, especially its focus on the digital media supply chain, will complement and extend the Qvest Group’s portfolio and lay the foundation to gain a foothold on the US-American market.
Headquartered in Los Angeles, with additional offices in New York and Austin, OnPrem is an end-to-end solution provider that strategizes, advises, designs and develops technology solutions, leveraging their expertise in content, customers and data for media and entertainment and consumer products industries. The acquisition brings a highly experienced team of more than 250 consultants to deliver solutions in areas such as Digital Media Supply Chain, IP and Rights Management, Data and Analytics, Customer Experience Design, Salesforce and Program Management/PMO to the Qvest Group. OnPrem has built dynamic partnerships with leading technology providers and platforms such as AWS, Salesforce and Microsoft.
“OnPrem strengthens the position of the Qvest Group as a leading partner in digital media, data and cloud management and considerably enhances our capacity to provide clients with added value, scale, and world-class expertise,” said Peter Nöthen, CEO of the Qvest Group. “For Qvest, this is also the steppingstone to the largest market for broadcast & media in the world which significantly raises our international business in technology consultancy and systems integration. Moreover, joining forces with OnPrem enables us to better and directly support worldwide operating clients and it also generates the ground for the growth of our cloud management platform qibb in the US-American market.”
Frank Leal, Partner at OnPrem, agrees: “The leadership at OnPrem is excited and inspired by our new Qvest partnership. With Qvest’s focus on the media industry and quality and their international presence, there was no better fit for us. This transaction creates a worldwide entity that is a partner to CTOs, CIOs and Broadcast Engineers everywhere. Most importantly, we were able to join a leadership team with a similar philosophy on culture and talent, providing additional opportunities for our team members and creating an organization that is a home to the best consultants and engineers in the world.”
The Qvest Group, headquartered in Germany, has offices across Europe, the Middle East, APAC, and Australia. The company has been accelerating the digital transformation of its clients, offering capabilities in technology design consultancy and systems integration, software development, cloud engineering, and technical infrastructure operations.
For OnPrem, Qvest’s service offerings and global scale will help to meet its clients’ growing needs for architecture design, seamless technology integration and realizing large-scaled media infrastructure projects along the entire digital media value chain.
As part of the acquisition, the Qvest Group acquired 55 % of the shares in OnPrem. The contract was signed on December 2, 2020. The partners at OnPrem, Frank Leal, Candice Lu, Christophe Ponsart, Jon Christian, and Vanessa Fiola, along with leadership will continue to build on its long-standing, valued relationships with employees and clients.
About Qvest Group
Qvest is a world-leading systems architect, consultant and ICT integrator in the innovation-driven media industry. The company’s range of services is aligned to the opportunities emerging from an increasingly digital media value chain such as multi-platform content delivery, AI, big data analysis, multi-cloud management and IP infrastructures. Qvest Media’s clients include renowned media networks, telecommunication providers, broadcasters, companies and organizations from the industrial and public sector. Next to the headquarters in Cologne, Qvest Media operates further locations in Europe, the USA, MENA & APAC.
About OnPrem
OnPrem Solution Partners is an end-to-end solution provider that strategizes, advises, designs, develops and integrates world-class technology. Experts in Digital Media Supply Chain, IP and Rights Management, CRM, AI, Data & Analytics, PMO/Project management and custom development, OnPrem connects disparate parts of an organization to enable operational excellence. Based in Los Angeles with offices in New York and Austin Texas, OnPrem offers its expertise within the Media & Entertainment, Consumer Packaged Goods industries and more.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201208006050/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom